医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2012年
32期
81
,共1页
邓晓苑%谢友许%李嘉%王海%张恒铭
鄧曉苑%謝友許%李嘉%王海%張恆銘
산효원%사우허%리가%왕해%장항명
氨磺必利%氯氮平%碳酸锂%躁狂症
氨磺必利%氯氮平%碳痠鋰%躁狂癥
안광필리%록담평%탄산리%조광증
amisulpride%clozapine%lithium carbonate%mania
目的探讨氨磺必利和氯氮平分别合并碳酸锂治疗女性躁狂发作的临床疗效.方法选择2011年7月至2012年7月我院精神科收治的72例女性躁狂症患者随机分为研究组和对照组治疗8周,研究组采用氨磺必利合并碳酸锂进行治疗;对照组采用氯氮平合并碳酸锂进行治疗.于治疗前和第1、2、4、8周末以 Bech-Rafaelsen 躁狂量表(BRMS)评定病情的严重程度,耐受性的评价采用不良反应量表(TESS)及相关辅助检查.结果两组治疗前后 BRMS 评分差异均有统计学意义(P<0.05),两组治疗有效率当,研究组不良反应发生率明显低于对照组(P<0.05).结论氨磺必利合并碳酸锂与氯氮平合并碳酸锂治疗女性躁狂发作总体有效率相当,但氨磺必利合并碳酸锂不良反应较轻,治疗依从性好,更适用于治疗女性急性躁狂发作患者.
目的探討氨磺必利和氯氮平分彆閤併碳痠鋰治療女性躁狂髮作的臨床療效.方法選擇2011年7月至2012年7月我院精神科收治的72例女性躁狂癥患者隨機分為研究組和對照組治療8週,研究組採用氨磺必利閤併碳痠鋰進行治療;對照組採用氯氮平閤併碳痠鋰進行治療.于治療前和第1、2、4、8週末以 Bech-Rafaelsen 躁狂量錶(BRMS)評定病情的嚴重程度,耐受性的評價採用不良反應量錶(TESS)及相關輔助檢查.結果兩組治療前後 BRMS 評分差異均有統計學意義(P<0.05),兩組治療有效率噹,研究組不良反應髮生率明顯低于對照組(P<0.05).結論氨磺必利閤併碳痠鋰與氯氮平閤併碳痠鋰治療女性躁狂髮作總體有效率相噹,但氨磺必利閤併碳痠鋰不良反應較輕,治療依從性好,更適用于治療女性急性躁狂髮作患者.
목적탐토안광필리화록담평분별합병탄산리치료녀성조광발작적림상료효.방법선택2011년7월지2012년7월아원정신과수치적72례녀성조광증환자수궤분위연구조화대조조치료8주,연구조채용안광필리합병탄산리진행치료;대조조채용록담평합병탄산리진행치료.우치료전화제1、2、4、8주말이 Bech-Rafaelsen 조광량표(BRMS)평정병정적엄중정도,내수성적평개채용불량반응량표(TESS)급상관보조검사.결과량조치료전후 BRMS 평분차이균유통계학의의(P<0.05),량조치료유효솔당,연구조불량반응발생솔명현저우대조조(P<0.05).결론안광필리합병탄산리여록담평합병탄산리치료녀성조광발작총체유효솔상당,단안광필리합병탄산리불량반응교경,치료의종성호,경괄용우치료녀성급성조광발작환자.
Objective: To investigate the amisulpride and clozapine combined with lithium in the clinical efficacy of the treatment of women with manic episodes.Method: Select 2011 July 2012 our hospital psychiatric admitted 72 cases of female patients with mania were randomly divided into treatment for eight weeks of the study group and the control group, the study group was treated with amisulpride treatment combined with lithium;control group using clozapine combined with lithium treatment. Before treatment and 1,2,4,8 weekend Bech-Rafaelsen Mania Rating Scale (BRMS) assess the severity of the disease, tolerance evaluation of adverse reaction scale (TESS) and laboratory examinations. Results: two groups before and after treatment BRMS score differences were statisticaly significant (P <0.05), treatment in the two groups when the study group incidence of adverse reactions was significantly lower than the control group (P <0.05). Conclusion: amisulpride Lee combined with lithium and clozapine combined with lithium in the treatment of women overal efficiency quite manic, but combined with lithium amisulpride the lighter adverse reactions, treatment compliance, and more applicable to the treatment of women with acute patients with manic episodes.